Y-Intercept (HK)’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
CWP
FWIA
ORIO
CNB
Y-Intercept (HK)'s PFE Position: Q2 2026 in Review
Y-Intercept (HK) sold out of Pfizer (PFE) in Q2 2026, closing a stake of 299,137 shares — an estimated $8.4M sold.
Y-Intercept (HK) first reported a position in PFE in Q4 2020 and held it in 14 quarters. The position peaked at $8.4M in Q1 2026. 705 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Y-Intercept (HK) reported no remaining Pfizer position as of Q2 2026 after selling out during the quarter.
- Y-Intercept (HK) sold 299,137 Pfizer shares in Q2 2026, an estimated $8.4M.
- Y-Intercept (HK) first reported a position in Pfizer in Q4 2020 and held it in 14 quarters.
- Y-Intercept (HK)'s Pfizer position peaked at $8.4M in Q1 2026.
- 705 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Y-Intercept (HK)'s 13F filing for Q2 2026, filed 14 Jul 2026.